Stocks Health care DVA
NYSE · Health careDavita Inc. (DVA)
Davita Inc. brought in $14.2B of revenue over the twelve months to September 30, 2026, up 6.4% from a year earlier. Net income was $920.1M, a net margin of 6.5%. Operating cash flow minus capital spending left $1.3B of free cash flow in fiscal 2025. At September 30, 2026 it held $495.6M in cash against $10.8B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.
Key facts about Davita Inc.
- Net worth
- Davita Inc. has a market value (market cap) of $11.8B at the latest share price, and shareholders' equity of -$591.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $13.6B (+6.5% year on year), with net income of $746.8M. Over the 12 months to September 30, 2026: revenue $14.2B, net income $920.1M.
- Cash flow
- In fiscal 2025 operations brought in $1.9B of cash; after $575.9M of capital spending, free cash flow was $1.3B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Davita Inc.'s next report is expected around February 1, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Davita Inc. does
Davita Inc. is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NYSE under the ticker DVA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $13.6B | $746.8M | $9.84 | $1.3B |
| 2024 | $12.8B | $936.3M | $10.73 | $1.5B |
| 2023 | $12.1B | $691.5M | $7.42 | $1.5B |
| 2022 | $11.6B | $560.4M | $5.85 | $961.1M |
| 2021 | $11.6B | $978.5M | $8.90 | $1.3B |
| 2020 | $11.6B | $773.6M | $6.31 | $1.3B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where DVA ranks in Health care
Latest SEC filings
What Davita Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 29, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 4.6% to $3.6B versus the same quarter last year; diluted EPS $3.40 versus $2.04.
- October 29, 2026
- August 4, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 5.2% to $3.6B versus the same quarter last year; diluted EPS $4.02 versus $2.58.
- August 4, 2026
- June 17, 2026
- June 8, 2026
- May 5, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 6% to $3.4B versus the same quarter last year; diluted EPS $2.87 versus $2.00.
- May 5, 2026
- April 22, 2026
- April 22, 2026Additional proxy material DEFA14A
What is DVA worth? A DCF from its reported cash flow
Insider trades
What the people running Davita Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $69M worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 27, 2026 | Berkshire Hathaway Inc10% owner | Soldindirect | 382,563 | $69M |
| September 22, 2026 | Maughan David PaulChief Operating Officer, DKC | Shares withheld for tax | 7,501 | $1.4M |
| August 15, 2026 | Yale Phyllis RDirector | Received as pay | 278 | - |
| August 15, 2026 | Arway Pamela MDirector | Received as pay | 278 | - |
| August 15, 2026 | Schoppert Wendy LeeDirector | Received as pay | 278 | - |
| August 15, 2026 | Pullin Dennis WDirector | Received as pay | 278 | - |
| August 15, 2026 | Moore Gregory J.Director | Received as pay | 278 | - |
| August 15, 2026 | Schechter Adam HDirector | Received as pay | 278 | - |
Who owns DVA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 630 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Berkshire Hathaway Inc | 28,880,209 | -1,220,376 |
| BlackRock, Inc. | 2,460,987 | -305,764 |
| Vanguard Capital Management LLC | 2,101,425 | -78,800 |
| Morgan Stanley | 1,601,710 | -64,328 |
| Vanguard Portfolio Management LLC | 1,377,914 | -101,686 |
| State Street Corp | 1,323,019 | -28,718 |
| Invesco Ltd. | 1,211,917 | -255,964 |
| Dimensional Fund Advisors LP | 1,137,814 | -7,622 |
| Neuberger Berman Group LLC | 925,579 | +393,492 |
| Arrowstreet Capital, Limited Partnership | 889,082 | -221,069 |
| Geode Capital Management, LLC | 853,602 | -86,179 |
| Gates Capital Management, Inc. | 688,136 | -34,872 |
| Bank of America Corp | 651,999 | +410,940 |
| D. E. Shaw & Co., Inc. | 640,827 | +136,188 |
| Aqr Capital Management LLC | 587,758 | +177,744 |
| Goldman Sachs Group Inc | 463,381 | +15,959 |
| Bank of New York Mellon Corp | 454,545 | -2,948 |
| Nordea Investment Management AB | 395,687 | +10,978 |
| Northern Trust Corp | 382,037 | -31,192 |
| Charles Schwab Investment Management Inc | 365,569 | -18,073 |
Insiders
15 insiders reported holding 29,586,810 shares in total, about $5.49B at the last price.
| Holder | Shares |
|---|---|
| Berkshire Hathaway Inc10% owner | 28,314,66628,314,666 held indirectly |
| Rodriguez JavierChief Executive Officer, Director | 840,408 |
| Ackerman JoelCFO and Treasurer | 132,434 |
| Waters Kathleen AlyceChief Legal & Pub. Affairs Off | 109,194 |
| Maughan David PaulChief Operating Officer, DKC | 86,604 |
| Arway Pamela MDirector | 27,223 |
| Hearty James OChief Compliance Officer | 22,389 |
| Berry Christopher MichaelChief Accounting Officer | 19,640 |
| Yale Phyllis RDirector | 9,803 |
| Moore Gregory J.Director | 8,091 |
Questions about DVA
What does Davita Inc. do?
Davita Inc. is a company in the Health care sector, listed on NYSE as DVA. Its shares trade on NYSE under the ticker DVA.
What is Davita Inc.'s net worth?
Davita Inc. has a market value (market cap) of $11.8B at the latest share price, and shareholders' equity of -$591.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Davita Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $920.1M on revenue of $14.2B, a net margin of 6.5%.
How much revenue does Davita Inc. make?
Over the twelve months to September 30, 2026 Davita Inc. reported revenue of $14.2B. That is 6.4% more than a year earlier.
When did Davita Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026.
When is Davita Inc.'s next earnings report?
Davita Inc.'s next report is expected around February 1, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare DVA with
Follow DVA
Get an email when Davita Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Davita Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.